February 26, 2020 / 11:03 PM / a month ago

BRIEF-Eloxx Pharmaceuticals Says Board Approved Leadership And Organizational Re-Alignment

Feb 26 (Reuters) - Eloxx Pharmaceuticals Inc:

* ELOXX PHARMACEUTICALS INC - ON FEB 24, BOARD APPROVED A LEADERSHIP AND ORGANIZATIONAL RE-ALIGNMENT

* ELOXX PHARMACEUTICALS - ORGANIZATIONAL RE-ALIGNMENT WILL RESULT IN ELIMINATION OF 13 FULL-TIME POSITIONS

* ELOXX PHARMACEUTICALS - CHANGES AS A RESULT OF ORGANIZATIONAL RE-ALIGNMENT WILL TAKE PLACE EFFECTIVE MAR 1

* ELOXX PHARMACEUTICALS INC - AS A RESULT OF RE-ALIGNMENT, EXPECTS TO ACHIEVE ANNUAL COST SAVINGS OF ABOUT $4.9 MILLION

* ELOXX PHARMACEUTICALS- AS A RESULT OF RE-ALIGNMENT, EXPECTS TO INCUR ONE-TIME PRE-TAX CHARGE, CONSISTING OF EMPLOYEE SEPARATION COSTS OF ABOUT $1.7 MILLION Source: (bit.ly/32xfG3v) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below